Global Kidney-Organ Chip Supply, Demand and Key Producers, 2026-2032
The global Kidney-Organ Chip market size is expected to reach $ 74.30 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).
A Kidney-Organ Chip, more commonly described as a Kidney Organ-on-a-Chip, is a microengineered in vitro platform designed to reproduce selected structural, mechanical, and physiological characteristics of the human kidney. The system combines human renal cells with microfluidic channels, porous membranes, extracellular matrices, controlled perfusion, and biochemical stimulation to simulate kidney functions under dynamic conditions. Depending on the model design, it may replicate the glomerular filtration barrier, proximal-tubule secretion and reabsorption, distal-tubule transport, collecting-duct function, renal vasculature, or interactions among several nephron segments. Kidney-Organ Chips are primarily used in nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic research, and development of personalized therapies. The market scope includes blank microfluidic chips, cell-loaded assay-ready models, kidney organoid-on-chip products, perfusion instruments, pumps, sensors, culture media, cells, software, analytical services, customized model development, training, and maintenance. These products are laboratory research and drug-development tools rather than implantable chips, dialysis systems, or therapeutic artificial kidneys.
This report is a detailed and comprehensive analysis of the world market for Kidney-Organ Chip, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney-Organ Chip that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Kidney-Organ Chip market
2. What is the demand of the global Kidney-Organ Chip market?
3. What is the year over year growth of the global Kidney-Organ Chip market?
4. What is the total value of the global Kidney-Organ Chip market?
5. Who are the Major Players in the global Kidney-Organ Chip market?
6. What are the growth factors driving the market demand?
A Kidney-Organ Chip, more commonly described as a Kidney Organ-on-a-Chip, is a microengineered in vitro platform designed to reproduce selected structural, mechanical, and physiological characteristics of the human kidney. The system combines human renal cells with microfluidic channels, porous membranes, extracellular matrices, controlled perfusion, and biochemical stimulation to simulate kidney functions under dynamic conditions. Depending on the model design, it may replicate the glomerular filtration barrier, proximal-tubule secretion and reabsorption, distal-tubule transport, collecting-duct function, renal vasculature, or interactions among several nephron segments. Kidney-Organ Chips are primarily used in nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic research, and development of personalized therapies. The market scope includes blank microfluidic chips, cell-loaded assay-ready models, kidney organoid-on-chip products, perfusion instruments, pumps, sensors, culture media, cells, software, analytical services, customized model development, training, and maintenance. These products are laboratory research and drug-development tools rather than implantable chips, dialysis systems, or therapeutic artificial kidneys.
Key Findings
- In 2025, global production of Kidney-Organ Chip was approximately 22,599 units.
- Commercial models concentrate on proximal tubule and nephrotoxicity applications
- Human cells and controlled perfusion improve renal physiological relevance
- Drug developers and research institutions remain the primary customer groups
- Assay-ready systems reduce operational barriers for pharmaceutical laboratories
- Standardization and regulatory validation determine long-term market scalability
Market Trends
Kidney-Organ Chip technology is progressing from basic single-channel cell-culture devices toward multicellular, vascularized, organoid-based, and interconnected renal models. Developers increasingly use human primary cells, immortalized renal cell lines, induced pluripotent stem-cell-derived cells, and adult stem-cell-derived organoids to improve physiological relevance. Dynamic perfusion and controlled shear stress support cell polarity, transporter expression, and long-term renal function. Another major trend is the development of standardized, microplate-compatible products that support automated liquid handling, high-content imaging, and medium- to high-throughput compound testing. Cell-loaded assay-ready models are becoming more important because they reduce model-establishment time and operator-dependent variability. Integrated sensors, real-time imaging, artificial-intelligence-assisted analysis, and transcriptomic or proteomic measurements are expanding functional readouts. Multi-organ configurations linking the kidney with the liver, intestine, heart, muscle, or immune system are also gaining attention for evaluating drug metabolism, systemic exposure, renal clearance, and inter-organ toxicity. These developments are gradually moving Kidney-Organ Chips from academic prototypes toward practical preclinical tools.Market Dynamics
Market development reflects the interaction between growing demand for human-relevant preclinical models and the technical difficulty of reproducing kidney physiology. Traditional animal models and static cell cultures may not fully represent human transporter expression, renal blood flow, tubular shear stress, metabolic activity, or species-specific drug responses. This limitation creates demand for dynamic human-cell-based models. Regulatory interest in new approach methodologies is encouraging pharmaceutical and biotechnology companies to assess microphysiological systems in safety and efficacy programs. However, commercial adoption remains selective because users must validate chip-generated results against conventional cell assays, animal studies, clinical biomarkers, and historical compound data. Purchasing decisions therefore involve scientific collaboration, sample testing, protocol development, and internal qualification. Suppliers must demonstrate biological relevance as well as batch consistency, stable cell sourcing, practical operation, analytical reliability, and acceptable cost per experiment. Partnerships among platform developers, cell suppliers, pharmaceutical companies, contract research organizations, universities, and regulatory laboratories remain central to industry development.Drivers
The primary market driver is the need to detect drug-induced kidney injury earlier and more accurately during pharmaceutical development. Renal toxicity can result in program termination, clinical failure, restricted dosing, additional monitoring requirements, or post-market safety concerns. Conventional models may not reproduce the polarity, transporter activity, fluid flow, and epithelial-vascular interactions of the human kidney. Kidney-Organ Chips provide controlled environments for measuring drug exposure, secretion, reabsorption, permeability, biomarker release, and tissue injury over time. Growing research activity in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited renal disorders is also expanding demand for human disease models. Additional growth factors include advances in microfluidics, stem-cell differentiation, organoid culture, three-dimensional tissue engineering, and automated imaging. Policies promoting alternatives to animal testing and pharmaceutical investment in human-relevant models further support adoption. Together, these drivers are extending Kidney-Organ Chip use from academic research to mechanistic toxicology, compound screening, translational studies, and preclinical decision support.Restraints
Commercial expansion is restrained by the biological complexity of the kidney and the lack of universally accepted validation standards. The kidney contains multiple nephron segments, specialized epithelial cells, endothelial cells, stromal cells, immune components, and complex vascular structures responsible for filtration, secretion, reabsorption, concentration, and endocrine regulation. Most commercial models reproduce only selected functions rather than the complete organ. Human primary renal cells may exhibit donor variability and limited expansion, while immortalized or stem-cell-derived cells may not fully achieve adult tissue maturity. Microfluidic systems may experience bubbles, evaporation, contamination, inconsistent flow, material absorption, and operational complexity. Customers can also require specialized pumps, imaging equipment, analytical methods, and trained personnel. Differences in chip geometry, cell type, extracellular matrix, medium, flow rate, exposure protocol, and endpoint selection reduce comparability between platforms. Until reference compounds, performance criteria, interlaboratory studies, and regulatory pathways become more established, Kidney-Organ Chips will mainly complement rather than completely replace existing preclinical methods.Opportunities
The strongest commercial opportunities lie in standardized and assay-ready Kidney-Organ Chip models that provide reproducible results with limited user preparation. Pharmaceutical companies require scalable platforms for nephrotoxicity screening, renal transporter analysis, biomarker assessment, compound prioritization, and mechanism-of-injury studies. Disease-specific models constructed from patient-derived cells or induced pluripotent stem cells offer opportunities in rare kidney diseases, inherited disorders, precision medicine, and individualized therapeutic development. Multi-organ systems connecting the kidney with the liver, intestine, muscle, heart, or immune system can support pharmacokinetic, metabolism, systemic toxicity, and organ-interaction studies. Suppliers can also expand through customized model development, contract testing, data analysis, regulatory consulting, software, training, and cell-and-reagent packages. Compatibility with automated laboratory workflows and standard microplate formats could accelerate adoption by large pharmaceutical organizations. China, Japan, and South Korea offer additional opportunities through expanding biopharmaceutical research, microfluidic manufacturing capabilities, organoid programs, and policies supporting alternatives to animal testing. Partnerships with contract research organizations and cell suppliers can further strengthen market access.Challenges
The principal challenge is generating biologically meaningful and repeatable data suitable for pharmaceutical and regulatory decisions. Renal cells must maintain appropriate polarity, transporter expression, barrier integrity, metabolic activity, and responses to physiological flow throughout the required culture period. Variations in cell source, extracellular matrix, medium composition, chip material, flow conditions, and dosing procedures can materially affect results. Developers must also establish clinically relevant endpoints, including transport activity, permeability, morphology, gene expression, tissue-injury biomarkers, and recovery responses. Scaling from laboratory prototypes to standardized commercial products requires consistent microfabrication, membrane quality, surface treatment, sterilization, cell loading, packaging, storage, and shipment. Another challenge is balancing physiological complexity with throughput and operational simplicity. Highly complex vascularized or multi-organ models may offer stronger biological relevance but can be more difficult and expensive to operate. Wider adoption will require reference-compound testing, transparent performance benchmarks, standardized data formats, interlaboratory validation, and clearer regulatory acceptance of Kidney-Organ Chip evidence.Industry Chain Analysis
The upstream industry includes microfluidic polymers, glass substrates, porous membranes, extracellular matrices, surface coatings, renal cells, stem cells, organoids, culture media, growth factors, pumps, valves, tubing, sensors, imaging systems, and laboratory automation equipment. The quality of these inputs directly influences cell viability, flow stability, optical performance, compound absorption, and experimental reproducibility. Midstream companies design and manufacture microfluidic chips, integrate perfusion equipment, construct renal tissue models, optimize culture protocols, develop analytical software, validate biological functions, and provide assay-ready products or customized testing services. Their competitiveness depends on combining microengineering, cell biology, tissue engineering, pharmacology, and data analysis. Downstream customers include pharmaceutical and biotechnology companies, contract research organizations, universities, hospitals, government laboratories, chemical companies, cosmetics companies, and regulatory research institutions. Products reach customers through direct technical sales, specialized scientific distributors, collaborative development agreements, and contract-service models. Installation, training, model development, data interpretation, software support, and consumable supply constitute an important service layer.Value Chain Analysis
The physical chip is only one part of the Kidney-Organ Chip value chain. Greater value is created through qualified cell sourcing, biological model establishment, extracellular-matrix optimization, fluidic control, functional validation, analytical endpoints, software, and translational interpretation. Empty chips and general-purpose perfusion equipment provide flexibility but require users to possess advanced cell-culture and microfluidic expertise. Cell-loaded assay-ready models provide greater practical value by reducing model-development time, minimizing operator variability, and enabling customers to focus on compound testing. Customized services further enhance value by adapting models to specific renal diseases, drug mechanisms, biomarkers, or regulatory questions. Data analysis and application support become increasingly important when users need to correlate chip results with animal studies, clinical biomarkers, pharmacokinetic models, and internal decision systems. Recurring revenue can be generated from disposable chips, cells, media, reagents, software, maintenance, calibration, training, and contract assays. Companies integrating engineering capabilities with validated biological models are better positioned to capture value across the product lifecycle.Segment Insights
By simulated renal structure, Kidney-Organ Chips can be divided into glomerulus-on-chip, proximal-tubule-on-chip, distal-tubule or collecting-duct models, and integrated nephron or multi-organ systems. Proximal-tubule models represent the most commercially developed segment because they support nephrotoxicity, secretion, reabsorption, and transporter studies. By technical architecture, the market includes membrane-based dual-channel devices, three-dimensional matrix-embedded tubular models, organoid-on-chip platforms, vascularized renal models, and bioprinted chips. By product form, products can be classified into blank chips and consumables, cell-loaded assay-ready models, perfusion instruments and complete systems, and customized testing services. By cell source, models use primary human renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, or adult stem-cell-derived organoids. Major applications include drug-induced nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic and ADME analysis, and personalized medicine. Selection depends on biological complexity, throughput, repeatability, operating difficulty, and required analytical endpoints.Downstream Market Opportunities
Drug-induced nephrotoxicity testing represents the leading downstream opportunity because pharmaceutical developers need to identify compounds that damage glomerular, tubular, vascular, or interstitial tissues before clinical trials. Kidney-Organ Chips can support dose-response analysis, compound ranking, transporter studies, biomarker evaluation, and investigation of injury mechanisms. Renal disease modeling offers opportunities in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited disorders. Drug-transport and clearance models can improve understanding of secretion, reabsorption, metabolite handling, and drug-drug interactions. Multi-organ systems enable analysis of metabolites generated by the liver, substances absorbed through the intestine, and systemic toxicity involving the kidney and other tissues. Patient-derived cells and kidney organoids create longer-term opportunities in precision medicine and individualized therapy selection. Pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions are the primary customers, while chemical, cosmetics, food, and environmental-safety organizations represent additional demand for renal toxicity assessment.Regional Insights
North America is an important center for Kidney-Organ Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe has also established a strong position in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney models, multi-organ systems, perfusion equipment, or enabling technologies. The region benefits from established pharmaceutical research, microfluidics expertise, and policies supporting non-animal testing. Asia-Pacific is developing rapidly as China, Japan, and South Korea increase investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic laboratory equipment. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic fabrication and three-dimensional organ-chip development. Regional expansion will depend on pharmaceutical partnerships, local cell resources, technical-service networks, regulatory validation, and the availability of trained users.Competitive Landscape Analysis
The competitive landscape includes dedicated Kidney-Organ Chip suppliers, broader organ-on-a-chip platform companies, perfusion-system manufacturers, microfluidic-device producers, and contract model-development providers. Emulate offers a validated Kidney-Chip model, while MIMETAS provides perfused kidney models and kidney organoid tubules through its OrganoPlate platform. Nortis is recognized for proximal-tubule chips, and TissUse develops kidney-containing multi-organ systems. CN Bio and Hesperos provide platforms capable of incorporating kidney tissues into single- or multi-organ studies. Creative Biolabs offers customized Kidney-Organ Chip development, while Kirkstall, BEOnChip, InSphero, Fluigent, and Microfluidics Innovation Center provide adaptable organ-chip, perfusion, or renal-model solutions. Asian participants include Beijing Daxiang Biotech, Nanosystems Japan, and EDmicBio. Competitive differentiation centers on renal physiological relevance, validated function, reproducibility, throughput, ease of use, cell quality, automation, data analysis, application support, and regulatory credibility rather than on microfluidic-chip production capacity alone.Report Scope
This report studies the global Kidney-Organ Chip demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Kidney-Organ Chip, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney-Organ Chip that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Kidney-Organ Chip total market, 2021-2032, (USD Million)
- Global Kidney-Organ Chip total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Kidney-Organ Chip total market, key domestic companies, and share, (USD Million)
- Global Kidney-Organ Chip revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Kidney-Organ Chip total market by Type, CAGR, 2021-2032, (USD Million)
- Global Kidney-Organ Chip total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Kidney-Organ Chip market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Kidney-Organ Chip Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Kidney-Organ Chip Market, Segmentation by Type:
- Glomerular Chip
- Renal Tubule Chip
- Colliding Duct Chip
Global Kidney-Organ Chip Market, Segmentation by Structure:
- Membrane-Based Dual-Channel Type
- 3D Matrix-Embedded Tubular Type
Global Kidney-Organ Chip Market, Segmentation by Source:
- Primary Human Cell-Based Type
- Immortalized Cell Line-Based Type
- Stem Cell & Organoid-Based Type
Global Kidney-Organ Chip Market, Segmentation by Application:
- Hospitals
- Research Institutions
- Universities
- Others
Companies Profiled:
- Emulate
- Mimetas
- TissUse
- Valo Health
- CN Bio Innovations
- Draper Laboratory
- Nortis
- Xona Microfluidics
- SynVivo
- Beijing Daxiang Biotech
Key Questions Answered
1. How big is the global Kidney-Organ Chip market?2. What is the demand of the global Kidney-Organ Chip market?
3. What is the year over year growth of the global Kidney-Organ Chip market?
4. What is the total value of the global Kidney-Organ Chip market?
5. Who are the Major Players in the global Kidney-Organ Chip market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Kidney-Organ Chip Introduction
1.2 World Kidney-Organ Chip Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Kidney-Organ Chip Total Market by Region (by Headquarter Location)
1.3.1 World Kidney-Organ Chip Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.3 China Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.4 Europe Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.5 Japan Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.6 South Korea Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.7 ASEAN Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.8 India Based Company Kidney-Organ Chip Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Kidney-Organ Chip Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Kidney-Organ Chip Consumption Value (2021-2032)
2.2 World Kidney-Organ Chip Consumption Value by Region
2.2.1 World Kidney-Organ Chip Consumption Value by Region (2021-2026)
2.2.2 World Kidney-Organ Chip Consumption Value Forecast by Region (2027-2032)
2.3 United States Kidney-Organ Chip Consumption Value (2021-2032)
2.4 China Kidney-Organ Chip Consumption Value (2021-2032)
2.5 Europe Kidney-Organ Chip Consumption Value (2021-2032)
2.6 Japan Kidney-Organ Chip Consumption Value (2021-2032)
2.7 South Korea Kidney-Organ Chip Consumption Value (2021-2032)
2.8 ASEAN Kidney-Organ Chip Consumption Value (2021-2032)
2.9 India Kidney-Organ Chip Consumption Value (2021-2032)
3 WORLD KIDNEY-ORGAN CHIP COMPANIES COMPETITIVE ANALYSIS
3.1 World Kidney-Organ Chip Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Kidney-Organ Chip Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Kidney-Organ Chip in 2025
3.2.3 Global Concentration Ratios (CR8) for Kidney-Organ Chip in 2025
3.3 Kidney-Organ Chip Company Evaluation Quadrant
3.4 Kidney-Organ Chip Market: Overall Company Footprint Analysis
3.4.1 Kidney-Organ Chip Market: Region Footprint
3.4.2 Kidney-Organ Chip Market: Company Product Type Footprint
3.4.3 Kidney-Organ Chip Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Kidney-Organ Chip Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Kidney-Organ Chip Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Kidney-Organ Chip Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Kidney-Organ Chip Consumption Value Comparison
4.2.1 United States VS China: Kidney-Organ Chip Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Kidney-Organ Chip Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Kidney-Organ Chip Companies and Market Share, 2021-2026
4.3.1 United States Based Kidney-Organ Chip Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Kidney-Organ Chip Revenue, (2021-2026)
4.4 China Based Companies Kidney-Organ Chip Revenue and Market Share, 2021-2026
4.4.1 China Based Kidney-Organ Chip Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Kidney-Organ Chip Revenue, (2021-2026)
4.5 Rest of World Based Kidney-Organ Chip Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Kidney-Organ Chip Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Kidney-Organ Chip Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Kidney-Organ Chip Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Glomerular Chip
5.2.2 Renal Tubule Chip
5.2.3 Colliding Duct Chip
5.3 Market Segment by Type
5.3.1 World Kidney-Organ Chip Market Size by Type (2021-2026)
5.3.2 World Kidney-Organ Chip Market Size by Type (2027-2032)
5.3.3 World Kidney-Organ Chip Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY STRUCTURE
6.1 World Kidney-Organ Chip Market Size Overview by Structure: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Structure
6.2.1 Membrane-Based Dual-Channel Type
6.2.2 3D Matrix-Embedded Tubular Type
6.3 Market Segment by Structure
6.3.1 World Kidney-Organ Chip Market Size by Structure (2021-2026)
6.3.2 World Kidney-Organ Chip Market Size by Structure (2027-2032)
6.3.3 World Kidney-Organ Chip Market Size Market Share by Structure (2027-2032)
7 MARKET ANALYSIS BY SOURCE
7.1 World Kidney-Organ Chip Market Size Overview by Source: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Source
7.2.1 Primary Human Cell-Based Type
7.2.2 Immortalized Cell Line-Based Type
7.2.3 Stem Cell & Organoid-Based Type
7.3 Market Segment by Source
7.3.1 World Kidney-Organ Chip Market Size by Source (2021-2026)
7.3.2 World Kidney-Organ Chip Market Size by Source (2027-2032)
7.3.3 World Kidney-Organ Chip Market Size Market Share by Source (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Kidney-Organ Chip Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Research Institutions
8.2.3 Universities
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Kidney-Organ Chip Market Size by Application (2021-2026)
8.3.2 World Kidney-Organ Chip Market Size by Application (2027-2032)
8.3.3 World Kidney-Organ Chip Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Emulate
9.1.1 Emulate Details
9.1.2 Emulate Major Business
9.1.3 Emulate Kidney-Organ Chip Product and Services
9.1.4 Emulate Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Emulate Recent Developments/Updates
9.1.6 Emulate Competitive Strengths & Weaknesses
9.2 Mimetas
9.2.1 Mimetas Details
9.2.2 Mimetas Major Business
9.2.3 Mimetas Kidney-Organ Chip Product and Services
9.2.4 Mimetas Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Mimetas Recent Developments/Updates
9.2.6 Mimetas Competitive Strengths & Weaknesses
9.3 TissUse
9.3.1 TissUse Details
9.3.2 TissUse Major Business
9.3.3 TissUse Kidney-Organ Chip Product and Services
9.3.4 TissUse Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TissUse Recent Developments/Updates
9.3.6 TissUse Competitive Strengths & Weaknesses
9.4 Valo Health
9.4.1 Valo Health Details
9.4.2 Valo Health Major Business
9.4.3 Valo Health Kidney-Organ Chip Product and Services
9.4.4 Valo Health Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Valo Health Recent Developments/Updates
9.4.6 Valo Health Competitive Strengths & Weaknesses
9.5 CN Bio Innovations
9.5.1 CN Bio Innovations Details
9.5.2 CN Bio Innovations Major Business
9.5.3 CN Bio Innovations Kidney-Organ Chip Product and Services
9.5.4 CN Bio Innovations Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CN Bio Innovations Recent Developments/Updates
9.5.6 CN Bio Innovations Competitive Strengths & Weaknesses
9.6 Draper Laboratory
9.6.1 Draper Laboratory Details
9.6.2 Draper Laboratory Major Business
9.6.3 Draper Laboratory Kidney-Organ Chip Product and Services
9.6.4 Draper Laboratory Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Draper Laboratory Recent Developments/Updates
9.6.6 Draper Laboratory Competitive Strengths & Weaknesses
9.7 Nortis
9.7.1 Nortis Details
9.7.2 Nortis Major Business
9.7.3 Nortis Kidney-Organ Chip Product and Services
9.7.4 Nortis Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Nortis Recent Developments/Updates
9.7.6 Nortis Competitive Strengths & Weaknesses
9.8 Xona Microfluidics
9.8.1 Xona Microfluidics Details
9.8.2 Xona Microfluidics Major Business
9.8.3 Xona Microfluidics Kidney-Organ Chip Product and Services
9.8.4 Xona Microfluidics Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Xona Microfluidics Recent Developments/Updates
9.8.6 Xona Microfluidics Competitive Strengths & Weaknesses
9.9 SynVivo
9.9.1 SynVivo Details
9.9.2 SynVivo Major Business
9.9.3 SynVivo Kidney-Organ Chip Product and Services
9.9.4 SynVivo Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SynVivo Recent Developments/Updates
9.9.6 SynVivo Competitive Strengths & Weaknesses
9.10 Beijing Daxiang Biotech
9.10.1 Beijing Daxiang Biotech Details
9.10.2 Beijing Daxiang Biotech Major Business
9.10.3 Beijing Daxiang Biotech Kidney-Organ Chip Product and Services
9.10.4 Beijing Daxiang Biotech Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Beijing Daxiang Biotech Recent Developments/Updates
9.10.6 Beijing Daxiang Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Kidney-Organ Chip Industry Chain
10.2 Kidney-Organ Chip Upstream Analysis
10.3 Kidney-Organ Chip Midstream Analysis
10.4 Kidney-Organ Chip Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Kidney-Organ Chip Introduction
1.2 World Kidney-Organ Chip Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Kidney-Organ Chip Total Market by Region (by Headquarter Location)
1.3.1 World Kidney-Organ Chip Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.3 China Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.4 Europe Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.5 Japan Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.6 South Korea Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.7 ASEAN Based Company Kidney-Organ Chip Revenue (2021-2032)
1.3.8 India Based Company Kidney-Organ Chip Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Kidney-Organ Chip Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Kidney-Organ Chip Consumption Value (2021-2032)
2.2 World Kidney-Organ Chip Consumption Value by Region
2.2.1 World Kidney-Organ Chip Consumption Value by Region (2021-2026)
2.2.2 World Kidney-Organ Chip Consumption Value Forecast by Region (2027-2032)
2.3 United States Kidney-Organ Chip Consumption Value (2021-2032)
2.4 China Kidney-Organ Chip Consumption Value (2021-2032)
2.5 Europe Kidney-Organ Chip Consumption Value (2021-2032)
2.6 Japan Kidney-Organ Chip Consumption Value (2021-2032)
2.7 South Korea Kidney-Organ Chip Consumption Value (2021-2032)
2.8 ASEAN Kidney-Organ Chip Consumption Value (2021-2032)
2.9 India Kidney-Organ Chip Consumption Value (2021-2032)
3 WORLD KIDNEY-ORGAN CHIP COMPANIES COMPETITIVE ANALYSIS
3.1 World Kidney-Organ Chip Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Kidney-Organ Chip Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Kidney-Organ Chip in 2025
3.2.3 Global Concentration Ratios (CR8) for Kidney-Organ Chip in 2025
3.3 Kidney-Organ Chip Company Evaluation Quadrant
3.4 Kidney-Organ Chip Market: Overall Company Footprint Analysis
3.4.1 Kidney-Organ Chip Market: Region Footprint
3.4.2 Kidney-Organ Chip Market: Company Product Type Footprint
3.4.3 Kidney-Organ Chip Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Kidney-Organ Chip Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Kidney-Organ Chip Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Kidney-Organ Chip Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Kidney-Organ Chip Consumption Value Comparison
4.2.1 United States VS China: Kidney-Organ Chip Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Kidney-Organ Chip Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Kidney-Organ Chip Companies and Market Share, 2021-2026
4.3.1 United States Based Kidney-Organ Chip Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Kidney-Organ Chip Revenue, (2021-2026)
4.4 China Based Companies Kidney-Organ Chip Revenue and Market Share, 2021-2026
4.4.1 China Based Kidney-Organ Chip Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Kidney-Organ Chip Revenue, (2021-2026)
4.5 Rest of World Based Kidney-Organ Chip Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Kidney-Organ Chip Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Kidney-Organ Chip Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Kidney-Organ Chip Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Glomerular Chip
5.2.2 Renal Tubule Chip
5.2.3 Colliding Duct Chip
5.3 Market Segment by Type
5.3.1 World Kidney-Organ Chip Market Size by Type (2021-2026)
5.3.2 World Kidney-Organ Chip Market Size by Type (2027-2032)
5.3.3 World Kidney-Organ Chip Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY STRUCTURE
6.1 World Kidney-Organ Chip Market Size Overview by Structure: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Structure
6.2.1 Membrane-Based Dual-Channel Type
6.2.2 3D Matrix-Embedded Tubular Type
6.3 Market Segment by Structure
6.3.1 World Kidney-Organ Chip Market Size by Structure (2021-2026)
6.3.2 World Kidney-Organ Chip Market Size by Structure (2027-2032)
6.3.3 World Kidney-Organ Chip Market Size Market Share by Structure (2027-2032)
7 MARKET ANALYSIS BY SOURCE
7.1 World Kidney-Organ Chip Market Size Overview by Source: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Source
7.2.1 Primary Human Cell-Based Type
7.2.2 Immortalized Cell Line-Based Type
7.2.3 Stem Cell & Organoid-Based Type
7.3 Market Segment by Source
7.3.1 World Kidney-Organ Chip Market Size by Source (2021-2026)
7.3.2 World Kidney-Organ Chip Market Size by Source (2027-2032)
7.3.3 World Kidney-Organ Chip Market Size Market Share by Source (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Kidney-Organ Chip Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Research Institutions
8.2.3 Universities
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Kidney-Organ Chip Market Size by Application (2021-2026)
8.3.2 World Kidney-Organ Chip Market Size by Application (2027-2032)
8.3.3 World Kidney-Organ Chip Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Emulate
9.1.1 Emulate Details
9.1.2 Emulate Major Business
9.1.3 Emulate Kidney-Organ Chip Product and Services
9.1.4 Emulate Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Emulate Recent Developments/Updates
9.1.6 Emulate Competitive Strengths & Weaknesses
9.2 Mimetas
9.2.1 Mimetas Details
9.2.2 Mimetas Major Business
9.2.3 Mimetas Kidney-Organ Chip Product and Services
9.2.4 Mimetas Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Mimetas Recent Developments/Updates
9.2.6 Mimetas Competitive Strengths & Weaknesses
9.3 TissUse
9.3.1 TissUse Details
9.3.2 TissUse Major Business
9.3.3 TissUse Kidney-Organ Chip Product and Services
9.3.4 TissUse Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TissUse Recent Developments/Updates
9.3.6 TissUse Competitive Strengths & Weaknesses
9.4 Valo Health
9.4.1 Valo Health Details
9.4.2 Valo Health Major Business
9.4.3 Valo Health Kidney-Organ Chip Product and Services
9.4.4 Valo Health Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Valo Health Recent Developments/Updates
9.4.6 Valo Health Competitive Strengths & Weaknesses
9.5 CN Bio Innovations
9.5.1 CN Bio Innovations Details
9.5.2 CN Bio Innovations Major Business
9.5.3 CN Bio Innovations Kidney-Organ Chip Product and Services
9.5.4 CN Bio Innovations Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CN Bio Innovations Recent Developments/Updates
9.5.6 CN Bio Innovations Competitive Strengths & Weaknesses
9.6 Draper Laboratory
9.6.1 Draper Laboratory Details
9.6.2 Draper Laboratory Major Business
9.6.3 Draper Laboratory Kidney-Organ Chip Product and Services
9.6.4 Draper Laboratory Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Draper Laboratory Recent Developments/Updates
9.6.6 Draper Laboratory Competitive Strengths & Weaknesses
9.7 Nortis
9.7.1 Nortis Details
9.7.2 Nortis Major Business
9.7.3 Nortis Kidney-Organ Chip Product and Services
9.7.4 Nortis Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Nortis Recent Developments/Updates
9.7.6 Nortis Competitive Strengths & Weaknesses
9.8 Xona Microfluidics
9.8.1 Xona Microfluidics Details
9.8.2 Xona Microfluidics Major Business
9.8.3 Xona Microfluidics Kidney-Organ Chip Product and Services
9.8.4 Xona Microfluidics Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Xona Microfluidics Recent Developments/Updates
9.8.6 Xona Microfluidics Competitive Strengths & Weaknesses
9.9 SynVivo
9.9.1 SynVivo Details
9.9.2 SynVivo Major Business
9.9.3 SynVivo Kidney-Organ Chip Product and Services
9.9.4 SynVivo Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SynVivo Recent Developments/Updates
9.9.6 SynVivo Competitive Strengths & Weaknesses
9.10 Beijing Daxiang Biotech
9.10.1 Beijing Daxiang Biotech Details
9.10.2 Beijing Daxiang Biotech Major Business
9.10.3 Beijing Daxiang Biotech Kidney-Organ Chip Product and Services
9.10.4 Beijing Daxiang Biotech Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Beijing Daxiang Biotech Recent Developments/Updates
9.10.6 Beijing Daxiang Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Kidney-Organ Chip Industry Chain
10.2 Kidney-Organ Chip Upstream Analysis
10.3 Kidney-Organ Chip Midstream Analysis
10.4 Kidney-Organ Chip Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Kidney-Organ Chip Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Kidney-Organ Chip Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Kidney-Organ Chip Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Kidney-Organ Chip Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Kidney-Organ Chip Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Kidney-Organ Chip Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Kidney-Organ Chip Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Kidney-Organ Chip Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Kidney-Organ Chip Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Kidney-Organ Chip Players in 2025
Table 12. World Kidney-Organ Chip Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Kidney-Organ Chip Company Evaluation Quadrant
Table 14. Head Office of Key Kidney-Organ Chip Players
Table 15. Kidney-Organ Chip Market: Company Product Type Footprint
Table 16. Kidney-Organ Chip Market: Company Product Application Footprint
Table 17. Kidney-Organ Chip Mergers & Acquisitions Activity
Table 18. United States VS China Kidney-Organ Chip Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Kidney-Organ Chip Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Kidney-Organ Chip Companies, Headquarters (States, Country)
Table 21. United States Based Companies Kidney-Organ Chip Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Kidney-Organ Chip Revenue Market Share (2021-2026)
Table 23. China Based Kidney-Organ Chip Companies, Headquarters (Province, Country)
Table 24. China Based Companies Kidney-Organ Chip Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Kidney-Organ Chip Revenue Market Share (2021-2026)
Table 26. Rest of World Based Kidney-Organ Chip Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Kidney-Organ Chip Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Kidney-Organ Chip Revenue Market Share (2021-2026)
Table 29. World Kidney-Organ Chip Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Kidney-Organ Chip Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Kidney-Organ Chip Market Size by Type (2027-2032) & (USD Million)
Table 32. World Kidney-Organ Chip Market Size by Structure, (USD Million), 2021 & 2025 & 2032
Table 33. World Kidney-Organ Chip Market Size Value by Structure (2021-2026) & (USD Million)
Table 34. World Kidney-Organ Chip Market Size by Structure (2027-2032) & (USD Million)
Table 35. World Kidney-Organ Chip Market Size by Source, (USD Million), 2021 & 2025 & 2032
Table 36. World Kidney-Organ Chip Market Size Value by Source (2021-2026) & (USD Million)
Table 37. World Kidney-Organ Chip Market Size by Source (2027-2032) & (USD Million)
Table 38. World Kidney-Organ Chip Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Kidney-Organ Chip Market Size by Application (2021-2026) & (USD Million)
Table 40. World Kidney-Organ Chip Market Size by Application (2027-2032) & (USD Million)
Table 41. Emulate Basic Information, Manufacturing Base and Competitors
Table 42. Emulate Major Business
Table 43. Emulate Kidney-Organ Chip Product and Services
Table 44. Emulate Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Emulate Recent Developments/Updates
Table 46. Emulate Competitive Strengths & Weaknesses
Table 47. Mimetas Basic Information, Manufacturing Base and Competitors
Table 48. Mimetas Major Business
Table 49. Mimetas Kidney-Organ Chip Product and Services
Table 50. Mimetas Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Mimetas Recent Developments/Updates
Table 52. Mimetas Competitive Strengths & Weaknesses
Table 53. TissUse Basic Information, Manufacturing Base and Competitors
Table 54. TissUse Major Business
Table 55. TissUse Kidney-Organ Chip Product and Services
Table 56. TissUse Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TissUse Recent Developments/Updates
Table 58. TissUse Competitive Strengths & Weaknesses
Table 59. Valo Health Basic Information, Manufacturing Base and Competitors
Table 60. Valo Health Major Business
Table 61. Valo Health Kidney-Organ Chip Product and Services
Table 62. Valo Health Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Valo Health Recent Developments/Updates
Table 64. Valo Health Competitive Strengths & Weaknesses
Table 65. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 66. CN Bio Innovations Major Business
Table 67. CN Bio Innovations Kidney-Organ Chip Product and Services
Table 68. CN Bio Innovations Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CN Bio Innovations Recent Developments/Updates
Table 70. CN Bio Innovations Competitive Strengths & Weaknesses
Table 71. Draper Laboratory Basic Information, Manufacturing Base and Competitors
Table 72. Draper Laboratory Major Business
Table 73. Draper Laboratory Kidney-Organ Chip Product and Services
Table 74. Draper Laboratory Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Draper Laboratory Recent Developments/Updates
Table 76. Draper Laboratory Competitive Strengths & Weaknesses
Table 77. Nortis Basic Information, Manufacturing Base and Competitors
Table 78. Nortis Major Business
Table 79. Nortis Kidney-Organ Chip Product and Services
Table 80. Nortis Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Nortis Recent Developments/Updates
Table 82. Nortis Competitive Strengths & Weaknesses
Table 83. Xona Microfluidics Basic Information, Manufacturing Base and Competitors
Table 84. Xona Microfluidics Major Business
Table 85. Xona Microfluidics Kidney-Organ Chip Product and Services
Table 86. Xona Microfluidics Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Xona Microfluidics Recent Developments/Updates
Table 88. Xona Microfluidics Competitive Strengths & Weaknesses
Table 89. SynVivo Basic Information, Manufacturing Base and Competitors
Table 90. SynVivo Major Business
Table 91. SynVivo Kidney-Organ Chip Product and Services
Table 92. SynVivo Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SynVivo Recent Developments/Updates
Table 94. SynVivo Competitive Strengths & Weaknesses
Table 95. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
Table 96. Beijing Daxiang Biotech Major Business
Table 97. Beijing Daxiang Biotech Kidney-Organ Chip Product and Services
Table 98. Beijing Daxiang Biotech Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Beijing Daxiang Biotech Recent Developments/Updates
Table 100. Beijing Daxiang Biotech Competitive Strengths & Weaknesses
Table 101. Global Key Players of Kidney-Organ Chip Upstream (Raw Materials)
Table 102. Global Kidney-Organ Chip Typical Customers
Table 1. World Kidney-Organ Chip Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Kidney-Organ Chip Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Kidney-Organ Chip Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Kidney-Organ Chip Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Kidney-Organ Chip Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Kidney-Organ Chip Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Kidney-Organ Chip Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Kidney-Organ Chip Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Kidney-Organ Chip Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Kidney-Organ Chip Players in 2025
Table 12. World Kidney-Organ Chip Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Kidney-Organ Chip Company Evaluation Quadrant
Table 14. Head Office of Key Kidney-Organ Chip Players
Table 15. Kidney-Organ Chip Market: Company Product Type Footprint
Table 16. Kidney-Organ Chip Market: Company Product Application Footprint
Table 17. Kidney-Organ Chip Mergers & Acquisitions Activity
Table 18. United States VS China Kidney-Organ Chip Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Kidney-Organ Chip Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Kidney-Organ Chip Companies, Headquarters (States, Country)
Table 21. United States Based Companies Kidney-Organ Chip Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Kidney-Organ Chip Revenue Market Share (2021-2026)
Table 23. China Based Kidney-Organ Chip Companies, Headquarters (Province, Country)
Table 24. China Based Companies Kidney-Organ Chip Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Kidney-Organ Chip Revenue Market Share (2021-2026)
Table 26. Rest of World Based Kidney-Organ Chip Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Kidney-Organ Chip Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Kidney-Organ Chip Revenue Market Share (2021-2026)
Table 29. World Kidney-Organ Chip Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Kidney-Organ Chip Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Kidney-Organ Chip Market Size by Type (2027-2032) & (USD Million)
Table 32. World Kidney-Organ Chip Market Size by Structure, (USD Million), 2021 & 2025 & 2032
Table 33. World Kidney-Organ Chip Market Size Value by Structure (2021-2026) & (USD Million)
Table 34. World Kidney-Organ Chip Market Size by Structure (2027-2032) & (USD Million)
Table 35. World Kidney-Organ Chip Market Size by Source, (USD Million), 2021 & 2025 & 2032
Table 36. World Kidney-Organ Chip Market Size Value by Source (2021-2026) & (USD Million)
Table 37. World Kidney-Organ Chip Market Size by Source (2027-2032) & (USD Million)
Table 38. World Kidney-Organ Chip Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Kidney-Organ Chip Market Size by Application (2021-2026) & (USD Million)
Table 40. World Kidney-Organ Chip Market Size by Application (2027-2032) & (USD Million)
Table 41. Emulate Basic Information, Manufacturing Base and Competitors
Table 42. Emulate Major Business
Table 43. Emulate Kidney-Organ Chip Product and Services
Table 44. Emulate Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Emulate Recent Developments/Updates
Table 46. Emulate Competitive Strengths & Weaknesses
Table 47. Mimetas Basic Information, Manufacturing Base and Competitors
Table 48. Mimetas Major Business
Table 49. Mimetas Kidney-Organ Chip Product and Services
Table 50. Mimetas Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Mimetas Recent Developments/Updates
Table 52. Mimetas Competitive Strengths & Weaknesses
Table 53. TissUse Basic Information, Manufacturing Base and Competitors
Table 54. TissUse Major Business
Table 55. TissUse Kidney-Organ Chip Product and Services
Table 56. TissUse Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TissUse Recent Developments/Updates
Table 58. TissUse Competitive Strengths & Weaknesses
Table 59. Valo Health Basic Information, Manufacturing Base and Competitors
Table 60. Valo Health Major Business
Table 61. Valo Health Kidney-Organ Chip Product and Services
Table 62. Valo Health Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Valo Health Recent Developments/Updates
Table 64. Valo Health Competitive Strengths & Weaknesses
Table 65. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 66. CN Bio Innovations Major Business
Table 67. CN Bio Innovations Kidney-Organ Chip Product and Services
Table 68. CN Bio Innovations Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CN Bio Innovations Recent Developments/Updates
Table 70. CN Bio Innovations Competitive Strengths & Weaknesses
Table 71. Draper Laboratory Basic Information, Manufacturing Base and Competitors
Table 72. Draper Laboratory Major Business
Table 73. Draper Laboratory Kidney-Organ Chip Product and Services
Table 74. Draper Laboratory Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Draper Laboratory Recent Developments/Updates
Table 76. Draper Laboratory Competitive Strengths & Weaknesses
Table 77. Nortis Basic Information, Manufacturing Base and Competitors
Table 78. Nortis Major Business
Table 79. Nortis Kidney-Organ Chip Product and Services
Table 80. Nortis Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Nortis Recent Developments/Updates
Table 82. Nortis Competitive Strengths & Weaknesses
Table 83. Xona Microfluidics Basic Information, Manufacturing Base and Competitors
Table 84. Xona Microfluidics Major Business
Table 85. Xona Microfluidics Kidney-Organ Chip Product and Services
Table 86. Xona Microfluidics Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Xona Microfluidics Recent Developments/Updates
Table 88. Xona Microfluidics Competitive Strengths & Weaknesses
Table 89. SynVivo Basic Information, Manufacturing Base and Competitors
Table 90. SynVivo Major Business
Table 91. SynVivo Kidney-Organ Chip Product and Services
Table 92. SynVivo Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SynVivo Recent Developments/Updates
Table 94. SynVivo Competitive Strengths & Weaknesses
Table 95. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
Table 96. Beijing Daxiang Biotech Major Business
Table 97. Beijing Daxiang Biotech Kidney-Organ Chip Product and Services
Table 98. Beijing Daxiang Biotech Kidney-Organ Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Beijing Daxiang Biotech Recent Developments/Updates
Table 100. Beijing Daxiang Biotech Competitive Strengths & Weaknesses
Table 101. Global Key Players of Kidney-Organ Chip Upstream (Raw Materials)
Table 102. Global Kidney-Organ Chip Typical Customers
LIST OF FIGURES
Figure 1. Kidney-Organ Chip Picture
Figure 2. World Kidney-Organ Chip Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Kidney-Organ Chip Total Revenue (2021-2032) & (USD Million)
Figure 4. World Kidney-Organ Chip Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Kidney-Organ Chip Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 13. Kidney-Organ Chip Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 16. World Kidney-Organ Chip Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 18. China Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 23. India Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Kidney-Organ Chip by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Kidney-Organ Chip Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Kidney-Organ Chip Markets in 2025
Figure 27. United States VS China: Kidney-Organ Chip Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Kidney-Organ Chip Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Kidney-Organ Chip Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Kidney-Organ Chip Market Size Market Share by Type in 2025
Figure 31. Glomerular Chip
Figure 32. Renal Tubule Chip
Figure 33. Colliding Duct Chip
Figure 34. World Kidney-Organ Chip Market Size Market Share by Type (2021-2032)
Figure 35. World Kidney-Organ Chip Market Size by Structure, (USD Million), 2021 & 2025 & 2032
Figure 36. World Kidney-Organ Chip Market Size Market Share by Structure in 2025
Figure 37. Membrane-Based Dual-Channel Type
Figure 38. 3D Matrix-Embedded Tubular Type
Figure 39. World Kidney-Organ Chip Market Size Market Share by Structure (2021-2032)
Figure 40. World Kidney-Organ Chip Market Size by Source, (USD Million), 2021 & 2025 & 2032
Figure 41. World Kidney-Organ Chip Market Size Market Share by Source in 2025
Figure 42. Primary Human Cell-Based Type
Figure 43. Immortalized Cell Line-Based Type
Figure 44. Stem Cell & Organoid-Based Type
Figure 45. World Kidney-Organ Chip Market Size Market Share by Source (2021-2032)
Figure 46. World Kidney-Organ Chip Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Kidney-Organ Chip Market Size Market Share by Application in 2025
Figure 48. Hospitals
Figure 49. Research Institutions
Figure 50. Universities
Figure 51. Others
Figure 52. World Kidney-Organ Chip Market Size Market Share by Application (2021-2032)
Figure 53. Kidney-Organ Chip Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Kidney-Organ Chip Picture
Figure 2. World Kidney-Organ Chip Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Kidney-Organ Chip Total Revenue (2021-2032) & (USD Million)
Figure 4. World Kidney-Organ Chip Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Kidney-Organ Chip Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Kidney-Organ Chip Revenue (2021-2032) & (USD Million)
Figure 13. Kidney-Organ Chip Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 16. World Kidney-Organ Chip Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 18. China Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 23. India Kidney-Organ Chip Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Kidney-Organ Chip by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Kidney-Organ Chip Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Kidney-Organ Chip Markets in 2025
Figure 27. United States VS China: Kidney-Organ Chip Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Kidney-Organ Chip Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Kidney-Organ Chip Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Kidney-Organ Chip Market Size Market Share by Type in 2025
Figure 31. Glomerular Chip
Figure 32. Renal Tubule Chip
Figure 33. Colliding Duct Chip
Figure 34. World Kidney-Organ Chip Market Size Market Share by Type (2021-2032)
Figure 35. World Kidney-Organ Chip Market Size by Structure, (USD Million), 2021 & 2025 & 2032
Figure 36. World Kidney-Organ Chip Market Size Market Share by Structure in 2025
Figure 37. Membrane-Based Dual-Channel Type
Figure 38. 3D Matrix-Embedded Tubular Type
Figure 39. World Kidney-Organ Chip Market Size Market Share by Structure (2021-2032)
Figure 40. World Kidney-Organ Chip Market Size by Source, (USD Million), 2021 & 2025 & 2032
Figure 41. World Kidney-Organ Chip Market Size Market Share by Source in 2025
Figure 42. Primary Human Cell-Based Type
Figure 43. Immortalized Cell Line-Based Type
Figure 44. Stem Cell & Organoid-Based Type
Figure 45. World Kidney-Organ Chip Market Size Market Share by Source (2021-2032)
Figure 46. World Kidney-Organ Chip Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Kidney-Organ Chip Market Size Market Share by Application in 2025
Figure 48. Hospitals
Figure 49. Research Institutions
Figure 50. Universities
Figure 51. Others
Figure 52. World Kidney-Organ Chip Market Size Market Share by Application (2021-2032)
Figure 53. Kidney-Organ Chip Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
